(Q54494653)

30 May 2018

title

Identification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancer. (English)

1 reference

30 May 2018

author

Daniel Berney

8

1 reference

30 May 2018

Yong-Jie Lu

11

1 reference

30 May 2018

author name string

Guoping Ren

1

1 reference

30 May 2018

Xiaoyan Liu

2

1 reference

30 May 2018

Xueying Mao

3

1 reference

30 May 2018

Yanling Zhang

4

1 reference

30 May 2018

Elzbieta Stankiewicz

5

1 reference

30 May 2018

Lucy Hylands

6

1 reference

30 May 2018

Rongrong Song

7

1 reference

30 May 2018

Jeremy Clark

9

1 reference

30 May 2018

Colin Cooper

10

1 reference

30 May 2018

publication date

25 July 2012

1 reference

30 May 2018

Genes, Chromosomes and Cancer

published in

1 reference

30 May 2018

volume

51

1 reference

30 May 2018

issue

11

1 reference

30 May 2018

page(s)

1014-1023

1 reference

30 May 2018

Overdiagnosis and overtreatment of early detected prostate cancer

cites work

1 reference

Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations

21 January 2018

1 reference

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health

21 January 2018

1 reference

BRAF and KRAS mutations in prostatic adenocarcinoma

21 January 2018

1 reference

Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma

21 January 2018

1 reference

Long-term outcome among men with conservatively treated localised prostate cancer.

21 January 2018

1 reference

Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer

21 January 2018

1 reference

Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer

21 January 2018

1 reference

BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma.

21 January 2018

1 reference

Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2009

1 reference

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

21 January 2018

1 reference

Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma

21 January 2018

1 reference

The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein

21 January 2018

1 reference

TMPRSS2-ERG Gene Fusion and Clinicopathologic Characteristics of Korean Prostate Cancer Patients

21 January 2018

1 reference

Lack of BRAF activating mutations in prostate adenocarcinoma: a study of 93 cases

21 January 2018

1 reference

TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients

21 January 2018

1 reference

Akt-regulated pathways in prostate cancer

21 January 2018

1 reference

Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.

21 January 2018

1 reference

Raf kinases in cancer-roles and therapeutic opportunities

21 January 2018

1 reference

The impact of translocations and gene fusions on cancer causation

21 January 2018

1 reference

ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples

21 January 2018

1 reference

Infrequent RAS oncogene mutations in human prostate cancer

21 January 2018

1 reference

ras, p53 and HPV status in benign and malignant prostate tumors

21 January 2018

1 reference

Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer.

21 January 2018

1 reference

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma

21 January 2018

1 reference

Tumour markers in prostate cancer III: biomarkers in urine.

21 January 2018

1 reference

RAF protein-serine/threonine kinases: Structure and regulation

21 January 2018

1 reference

KRAS and BRAF mutations in prostate carcinomas of Chinese patients.

21 January 2018

1 reference

Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays

21 January 2018

1 reference

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

International comparison on ras gene mutations in latent prostate carcinoma

21 January 2018

1 reference

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

21 January 2018

1 reference

Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer

21 January 2018

1 reference

Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601.

21 January 2018

1 reference

PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events

21 January 2018

1 reference

7 January 2021

S-phase fraction related to prognosis in localised prostate cancer. No specific significance of chromosome 7 gain or deletion of 7q31.1.

1 reference

7 January 2021

Chromosomal changes in prostate cancer: a fluorescence in situ hybridization study

1 reference

7 January 2021

Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis

1 reference

7 January 2021

K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men

1 reference

7 January 2021

Comparison of ras activation in prostate carcinoma in Japanese and American men

1 reference

7 January 2021

Raf-1 expression may influence progression to androgen insensitive prostate cancer

1 reference

7 January 2021

Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.21984

1 reference

30 May 2018

1 reference

30 May 2018